By Counterforce Health Team in Exondys 51 (eteplirsen) —

Renewing Exondys 51 (Eteplirsen) Approval with Aetna in Georgia: 2025 Requirements, Timeline & Appeal Guide

Quick Answer: Renewing Your Exondys 51 Coverage

Start your Exondys 51 renewal 60-90 days before expiration. Aetna requires documented clinical benefit, adherence records, updated cardiac/respiratory function tests, and specialist oversight. If denied, you have 65 days to appeal in Georgia, with expedited 72-hour reviews available for urgent cases. Submit through CVS Caremark's portal with genetic confirmation, 6-minute walk test results, and prescriber attestation.

First step today: Check your Aetna member portal for your current authorization end date, then schedule cardiac echo and pulmonary function tests 45-60 days before expiration.

Table of Contents

When to Start Your Renewal

Don't wait until the last minute. Aetna's renewal process for Exondys 51 typically takes 30-45 days for standard review, and you'll need time to gather updated clinical evidence.

Key Renewal Triggers

Start 60-90 days early if:

  • Your child has had any hospitalizations or significant health changes
  • You've switched neurologists or treatment centers
  • Cardiac function has declined (LVEF approaching 50%)
  • There have been adherence issues or missed infusions

Start 45-60 days early for routine renewals when clinical status is stable and all monitoring is up to date.

Tip: Set a calendar reminder 90 days before your authorization expires. This gives you a buffer if additional testing is needed.

Required Documentation Checklist

Aetna requires proof of continued clinical benefit and appropriate monitoring. Here's what you'll need:

Essential Documents

Clinical Evidence (within 6 months):

  • Updated 6-Minute Walk Test results (must maintain ≥180-300 meters independently)
  • North Star Ambulatory Assessment (NSAA) score >17
  • Rise time measurement <7 seconds (Gowers sign)
  • Current weight for dosing verification

Cardiac Monitoring:

  • Echocardiogram showing LVEF >40% (ideally >50%)
  • EKG if indicated by prescriber

Respiratory Function:

  • Forced Vital Capacity (FVC) ≥50% predicted
  • Peak cough flow measurement

Laboratory Confirmation:

  • Genetic testing report confirming exon 51-amenable DMD mutation
  • Basic metabolic panel (BUN, creatinine for safety monitoring)
  • Urinalysis (checking for proteinuria)

Prescription & Provider Documentation

  • Updated prescription from neurologist or neuromuscular specialist
  • Provider attestation of continued clinical benefit
  • Documentation of adherence to weekly infusion schedule
  • Notes on any adverse events or medication adjustments

According to Aetna's clinical policy, genetic confirmation and specialist oversight remain mandatory for all renewals.

Monitoring Requirements for Renewal

Exondys 51 therapy requires ongoing monitoring to demonstrate continued benefit and safety. Here's what Aetna expects to see:

Cardiac Function Monitoring

LVEF (Left Ventricular Ejection Fraction) is the primary cardiac marker. Research shows Exondys 51 treatment significantly slows cardiac decline:

  • Treated patients: 0% reached LVEF <50% vs. 22.1% in untreated controls
  • Target for renewal: LVEF >40% (stable or improved from baseline)
  • Frequency: Echo every 6-12 months

DMD Progression Markers

Test Renewal Threshold Frequency
6-Minute Walk Test ≥180-300 meters Every 6 months
NSAA Score >17 Every 6 months
Rise Time <7 seconds Every 6 months
FVC ≥50% predicted Every 6-12 months
Note: The goal isn't improvement—it's slowing the rate of decline compared to natural history. Document stability or slower progression.

Renewal Submission Process

Step-by-Step Submission

  1. Gather Documentation (45-60 days before expiration)
    • Schedule required tests if not current
    • Request records from all providers
  2. Complete Prior Authorization Form
    • Use CVS Caremark's online portal or paper form
    • Include all required clinical documentation
  3. Submit via Appropriate Channel
    • Online: CVS Caremark provider portal (preferred)
    • Fax: Check your plan documents for current fax number
    • Mail: Include tracking for paper submissions
  4. Follow Up Within 7-10 Days
    • Confirm receipt through member portal
    • Provide any additional information requested

Expected Timeline

  • Standard review: 30-45 days
  • Expedited review: 72 hours (if medically urgent)
  • Appeal decision: 7 days (Georgia) or 72 hours (expedited)

Counterforce Health helps families navigate complex renewal requirements by analyzing denial patterns and crafting evidence-based appeals that align with Aetna's specific criteria.

Common Denial Reasons & Solutions

Denial Reason Solution Strategy
Insufficient clinical benefit Submit comparative data showing slowed progression vs. natural history; include 6MWT trends
Missing genetic confirmation Provide original genetic testing report confirming exon 51-amenable mutation
Non-specialist prescriber Transfer care to certified neuromuscular specialist; obtain co-signature if needed
Adherence concerns Submit pharmacy records showing consistent weekly dosing; address any missed infusions
Age/functional limits Document current ambulatory status; provide recent functional assessments

Medical Necessity Letter Tips

Your prescriber's letter should emphasize:

  • Continued ambulatory function despite DMD progression
  • Cardiac protection with stable or improved LVEF
  • Treatment response compared to expected natural decline
  • Safety profile with appropriate monitoring

Appeals Timeline for Georgia

If your renewal is denied, Georgia law provides specific protections and timelines:

Internal Appeals (Aetna)

Level 1 Appeal:

  • Deadline: 65 days from denial notice
  • Decision: 7 days (standard) or 72 hours (expedited)
  • Submit: Include updated clinical evidence, peer-reviewed studies supporting use

Level 2 Appeal:

  • Deadline: Per denial instructions
  • Decision: Same timelines as Level 1

Georgia External Review

If internal appeals fail, Georgia's Department of Insurance provides free, binding external review:

  • Deadline: 60 days from final internal denial
  • Decision: 15 days (standard) or 72 hours (expedited)
  • Contact: Georgia DOI at 1-800-656-2298
  • Cost: Free to consumers
Important: Georgia allows concurrent external review with expedited internal appeals if delay could harm your health.

When to Request Expedited Review

Request expedited review if standard timelines "could seriously jeopardize your life, health, or ability to regain maximum function." For Exondys 51, this applies when:

  • Current authorization expires before decision
  • Treatment interruption could accelerate muscle weakness
  • Cardiac function is declining and treatment delay poses risk

Coverage Gaps & Bridge Options

If your authorization expires before renewal approval, you have several options:

Immediate Steps

  1. Contact your prescriber to request expedited appeal citing medical urgency
  2. Call Aetna member services (number on your insurance card) to request emergency supply
  3. Contact SareptAssist at 888-SAREPTA for manufacturer support programs

Bridge Therapy Considerations

  • Emergency fills: Some plans allow 30-day emergency supplies during appeals
  • Manufacturer programs: May provide temporary medication while appeals are pending
  • Alternative funding: Patient assistance foundations may help bridge coverage gaps
Note: Never stop treatment abruptly. Work with your care team to maintain continuity during the appeals process.

2025 Formulary Changes

Aetna made several specialty medication changes effective January 1, 2025, though Exondys 51 wasn't specifically mentioned in available updates. However, key changes affecting specialty drugs include:

What to Verify for 2025

  • Prior authorization requirements: May have been updated
  • Quantity limits: Could affect dosing schedules
  • Preferred alternatives: New DMD treatments may be added
  • Site of care restrictions: Infusion location requirements

Check your specific plan's 2025 formulary at Aetna's drug lookup tool to confirm current coverage status.

For complex coverage issues, Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals that align with payer-specific requirements and clinical guidelines.

FAQ: Renewal Questions

How long does Aetna PA renewal take in Georgia? Standard renewals take 30-45 days. Expedited reviews are completed within 72 hours if medically urgent.

What if my child's function has declined since last approval? Document the rate of decline compared to natural history. Slower progression than expected can still justify continued treatment.

Can I appeal if Exondys 51 becomes non-formulary? Yes. Request a formulary exception with medical necessity documentation. Georgia's external review process applies to coverage denials.

Does step therapy apply to renewals? Generally no, if you're already established on therapy. However, document any concurrent treatments or changes in care.

What if we've moved to a new neurologist? Ensure the new provider is a qualified specialist and can access previous treatment records to document continued benefit.

How often do I need genetic testing? The original genetic confirmation typically suffices unless there are questions about the initial diagnosis.

What counts as "continued clinical benefit"? Stable or slower-than-expected decline in ambulatory function, maintained cardiac function, and adherence to treatment schedule.

Can I request peer-to-peer review? Yes. Your prescriber can request to speak directly with Aetna's medical director to discuss the case.

Disclaimer

This information is for educational purposes only and is not medical advice. Coverage policies and appeal procedures may change. Always verify current requirements with your insurance plan and consult your healthcare provider for medical decisions. For the most current Georgia insurance appeal information, contact the Georgia Department of Insurance at 1-800-656-2298.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.